Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate

Prognostic factor in the patients with benign prostatic hyperplasia (BPH) who undergo holmium laser enucleation of the prostate

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Benign Prostatic Hyperplasia (BPH) Genital Diseases Genital Diseases, Male Male Urogenital Diseases Prostatic Diseases Prostatic Hyperplasia Urogenital Diseases

Sex eligibility

Male

Study type

Observational

Primary location

Samsung Medical Center, Sungkyunkwan University School of Medicine

Seoul, 135-710, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male patient scheduled to undergo prostatectomy using holmium laser

Exclusion criteria

Urethral stricture, large bladder diverticulum, bladder neck contracture

Treatment and study plan

holmium laser enucleation of the prostate

Procedure

undergo holmium laser enucleation of the prostate

Primary outcomes

Comparison of IPSS(International Prostate Symptom Score) changes

Time frame: pre-operation and post-operation (3month, 6month)

Complete the questionnaire(IPSS) before and after the treatment

Secondary outcomes

changes of voided urine volume

Time frame: pre-operation and post-operation (3month, 6month)

Comparison of voided urine volume
changes of residual urine volume

Time frame: pre-operation and post-operation (3month, 6month)

Comparison of residual urine volume
Occurrence of adverse event

Time frame: post-operation (3month, 6month)

collection of adverse event

Sponsors and collaborators

Lead sponsor

Samsung Medical Center

Other

Registry information

Important dates

Study start: 2015
Primary completion: 2019
Study completion: 2019
First posted: Mar 9, 2018
Registry last updated: Dec 2, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed